Kamal Bakri - Concepedia

Author

Kamal Bakri

University of North Carolina at Chapel Hill

Also Known As

Berry, Donald A., KAMAL M. BAKRI, KAMAL M. BAKRI, M.D., Kamal Bakri, Niell, Harvey

Publications

321

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill NorthShore University HealthSystem

About

Kamal Bakri is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	194
2	Health Sciences	3	3	158
3	Cancer Therapeutics	3	3	166
4	Pathology	1	1	28
5	Pharmacology	1	1	36

Kamal Bakri

Publications

305

Citations

H-Index

Page 1

	Year	Citations
Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-Line Therapy in Advanced-Stage IIIB/IV Non–Small-Cell Lung Cancer Mark A. Socinski, Michael J. Schell, Amy H. Peterman, Journal of Clinical Oncology Advanced NsclcOptimal DurationMedicineCancer ManagementMetronomic Therapy	2002	120
Second‐line, low‐dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first‐line chemotherapy with carboplatin plus paclitaxel Mark A. Socinski, Michael J. Schell, Kamal Bakri, Cancer	2002	55
Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840—Cancer and Leukemia Group B Blasé N. Polite, Constance Cirrincione, Gini F. Fleming, Journal of Clinical Oncology	2008	37
A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer Thomas E. Stinchcombe, Amy H. Peterman, Carrie B. Lee, Journal of Thoracic Oncology OncologyElderly PatientsMedicineAge ≥70 YearsMetronomic Therapy	2011	36
Adenosquamous carcinoma of the thyroid after radiotherapy for Hodgkin's disease a case report and review Kamal Bakri, Katsutaro Shimaoka, Uma Rao, Cancer Health SciencesRadiation TherapyMedicineAdenosquamous CarcinomaThyroid Disease	1983	28
T-suppressor cell chronic lymphocytic leukemia. Phenotypic characterization by monoclonal antibodies Kamal Bakri, Ediz Z. Ezdinli, Larry P. Wasser, Cancer	1984	19
A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer Thomas E. Stinchcombe, Petra Bůžková, J. K. Choksi, Lung Cancer Geriatric OncologyElderly PatientsMedicineClinical TrialsWeekly Docetaxel	2006	10

Page 1